Pharmacokinetics Of Tigecycline In Morbidly Obese Subjects
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
If tigecycline clearance increases with body size then serum exposure values will be lower in
obese class III compared to normal weight subjects because exposure changes inversely with
clearance when the dose is fixed without regard to weight.